A general method for the selection of high-level scFv and IgG antibody expression by stably transfected mammalian cells
- 16 October 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Protein Engineering, Design and Selection
- Vol. 22 (3), 169-174
- https://doi.org/10.1093/protein/gzn068
Abstract
The isolation of mammalian cell lines capable of high-yield expression of recombinant antibodies is typically performed by screening multiple individual clones by limiting dilution techniques. A number of experimental strategies have recently been devised to identify high-expressing clones, but protocols are often difficult to implement, time consuming, costly and limited in terms of number of clones which can be screened. In this article, we describe new vectors for the expression of recombinant antibodies in IgG format and in other formats, based on the single-chain Fv module, as well as a high-throughput screening procedure, based on the direct staining of antibodies transiting the membrane of a stably transfected cell, followed by preparative sorting using a high-speed cell sorter. This procedure allows, in one step, to deposit single cells into individual wells of a 96-well microtiter plate (thus facilitating cloning) and to preferentially recover those rare cell populations which express dramatically higher levels of recombinant antibody. Using cell cultures followed by affinity purification techniques, we could confirm that the new vectors and the new screening procedure reliably yield high-expression clones and homogenous protein preparations. We expect that these techniques should find broad applicability for both academic and industrial antibody engineering research.Keywords
This publication has 39 references indexed in Scilit:
- Calcium phosphate transfection generates mammalian recombinant cell lines with higher specific productivity than polyfectionBiotechnology & Bioengineering, 2008
- Antibody-Drug Conjugates for Cancer TherapyThe Cancer Journal, 2008
- Antibody-based targeting of the tumor vasculatureBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2007
- Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectivesBiotechnology Letters, 2007
- Potent antibody therapeutics by designNature Reviews Immunology, 2006
- Use of the chicken lysozyme 5′ matrix attachment region to generate high producer CHO cell linesBiotechnology & Bioengineering, 2005
- Tumour vascular targetingNature Reviews Cancer, 2005
- The therapeutic antibodies market to 2008European Journal of Pharmaceutics and Biopharmaceutics, 2005
- Production of recombinant protein therapeutics in cultivated mammalian cellsNature Biotechnology, 2004
- By-passing immunisationJournal of Molecular Biology, 1992